C07K 16/088
Varicella-zoster virus
Official title: {Varicella-zoster virus}
C07K16/088 (Varicella-zoster virus) appears on 14 US grants and 14 published applications in this corpus.
Search patents in C07K- Granted patents
- 14
- Published applications
- 14
- Assignees
- 22
- Inventors
- 59
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-varicella-zoster virus antibody9 Dec 2025US 12,491,386 B2Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases17 Sep 2024US 12,090,202 B2Network Immunology Inc.
- Anti-varicella-zoster virus antibody, immunological measurement method, and immunological measurement device14 Nov 2023US 11,814,424 B2Tanaka Kikinzoku Kogyo K.K.
- Specific binding agents to varicella-zoster virus and uses related thereto19 Oct 2021US 11,147,870 B2Emory University
- Peptide tag for immunodetection and immunopurification3 Jul 2001US 6,255,462 B1University of Iowa Research Foundation
- Affinity and functional based screening of t cell receptor repertoire using three-dimensional shaped particles30 Jul 2026US 2026/0218282 A1The Regents of the University of California
- Herpes Zoster Treatment7 May 2026US 2026/0125453 A1Xbiotech, Inc.
- Therapeutic polynucleotides encoding t cell receptor (tcr) alpha chain polypeptides and/or tcr beta chain polypeptides29 Jan 2026US 2026/0027153 A1The Regents of the University of California
- Anti-varicella-zoster virus antibody and use thereof23 May 2024US 2024/0166725 A1Beijing Wisdomab Biotechnology Co., Ltd
- T cell antigen receptor, multimeric complex thereof and preparation method and use thereof17 Aug 2023US 2023/0257447 A1Bristar Immunotech Limited
Most cited
By later US patents
- Peptide tag for immunodetection and immunopurification43US 5,710,248 AUniversity of Iowa Research Foundation · 1998
- Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque29US 5,837,262 ABio-Virus Research Incorporated · 1998
- High titer varicella-zoster immune globulin for intravenous administration23US 4,665,159 AMiles Laboratories, Inc. · 1987
- High titer varicella-zoster immune globulin for intravenous administration12US 4,717,564 AMiles Laboratories, Inc. · 1988
- Mouse-human hybridoma which produces antivirus-human antibody, process for preparation thereof, and antivirus-human monoclonal antibody9US 4,950,595 ATeijin Limited · 1990